by Mike Masnick
Wed, Dec 3rd 2008 11:44am
One of the most ridiculous extensions of patent coverage in the past few decades was the decision to allow patents on "genes" for those who discover the genes. Patents aren't supposed to be allowed for things occurring in nature, and it's difficult to see how that doesn't apply to something as basic as genes. Yet, as an anonymous reader wrote in to point out, down in Australia, a company with a patent on a specific gene is causing babies with a severe form of epilepsy to have to delay both diagnosis and treatment. In fact, the delay in treating the babies may miss the sweet spot for treating the disease and preventing brain damage. When patents are being used to stop diagnosing a patient with a serious disease, we should all be asking how the system went so wrong.
If you liked this post, you may also be interested in...
- Will Australian Government Use Cost-Benefit Analysis To Kill Off Fair Use Proposal Once And For All?
- Why Patent Trolls Love East Texas... And Why Congress Needs To Fix It
- Australian Reporter Makes A Year's Worth Of His Metadata Available For Public To Rummage Through
- Could A Hedge Fund Manager Trying To Short Stocks Of Pharma Companies With Bad Patents Derail Patent Reform?
- Australian Court Rejects Dallas Buyers Club Copyright Trolling Demands